Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2022 3
2023 1
2024 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
Salazar de Pablo G, Pastor Jordá C, Vaquerizo-Serrano J, Moreno C, Cabras A, Arango C, Hernández P, Veenstra-VanderWeele J, Simonoff E, Fusar-Poli P, Santosh P, Cortese S, Parellada M. Salazar de Pablo G, et al. J Am Acad Child Adolesc Psychiatry. 2023 Feb;62(2):151-168. doi: 10.1016/j.jaac.2022.03.033. Epub 2022 Apr 22. J Am Acad Child Adolesc Psychiatry. 2023. PMID: 35470032 Free article.
OBJECTIVE: Emotional dysregulation and irritability are common in individuals with autism spectrum disorder (ASD). We conducted the first meta-analysis assessing the efficacy of a broad range of pharmacological interventions for em …
OBJECTIVE: Emotional dysregulation and irritability are common in individuals with autism spectrum disorder (ASD …
Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment.
Choi H, Kim JH, Yang HS, Kim JY, Cortese S, Smith L, Koyanagi A, Dragioti E, Radua J, Fusar-Poli P, Shin JI, Cheon KA, Solmi M. Choi H, et al. Mol Autism. 2024 Jan 23;15(1):7. doi: 10.1186/s13229-024-00585-6. Mol Autism. 2024. PMID: 38263251 Free PMC article.
BACKGROUND: Numerous interventions for irritability in autism spectrum disorder (ASD) have been investigated. We aimed to appraise the magnitude of pharmacological and non-pharmacological interventions for irritability in ASD witho …
BACKGROUND: Numerous interventions for irritability in autism spectrum disorder (ASD) have been investigated. We …
Effectiveness of pharmacological interventions for managing ADHD symptoms in individuals with autism spectrum disorder: A systematic review and meta-analysis.
Martins PLB, Torquato GCP, Dias GAPF, Leite IB, Gaspar TM, Pinto JP, Macedo DS. Martins PLB, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 30;134:111089. doi: 10.1016/j.pnpbp.2024.111089. Epub 2024 Jul 14. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 39004333
OBJECTIVES: This systematic review sought to provide evidence for the effectiveness of common pharmacological interventions used for treating attention deficit hyperactivity disorder (ADHD) symptoms in the autism spectrum disorder …
OBJECTIVES: This systematic review sought to provide evidence for the effectiveness of common pharmacological intervent …
Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY. Fung LK, et al. Pediatrics. 2016 Feb;137 Suppl 2:S124-35. doi: 10.1542/peds.2015-2851K. Pediatrics. 2016. PMID: 26908468
BACKGROUND: Autism spectrum disorder (ASD) is increasingly recognized as a public health issue. Irritability and aggression (IA) often negatively affect the lives of people with ASD and their families. Although many medications have been tested for IA …
BACKGROUND: Autism spectrum disorder (ASD) is increasingly recognized as a public health issue. Irritability and …
Second generation antipsychotics in Asperger's Disorder and high functioning autism: a systematic review of the literature and effectiveness of meta-analysis.
Sochocky N, Milin R. Sochocky N, et al. Curr Clin Pharmacol. 2013 Nov;8(4):370-9. doi: 10.2174/15748847113086660073. Curr Clin Pharmacol. 2013. PMID: 24050741
METHODS: We conducted a systematic review and meta-analysis of the recent English literature on SGA use in children and adolescents (ages 0-24 years) with AD and HFA using the Medline/PubMed and PsychINFO computerized databases. ...RESULTS: Our search …
METHODS: We conducted a systematic review and meta-analysis of the recent English literature on SGA use in child …
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, San José Cáceres A, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Siafis S, et al. Mol Autism. 2022 Mar 4;13(1):10. doi: 10.1186/s13229-022-00488-4. Mol Autism. 2022. PMID: 35246237 Free PMC article.
BACKGROUND: There is still no approved medication for the core symptoms of autism spectrum disorder (ASD). This network meta-analysis investigated pharmacological and dietary-supplement treatments for ASD. METHODS: We searched for …
BACKGROUND: There is still no approved medication for the core symptoms of autism spectrum disorder (ASD). This network …
Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis.
Liang SC, Sun CK, Fan HY, Chung W, Tzang RF, Hung KC, Chiu HJ, Cheng YS, Yeh PY. Liang SC, et al. J Psychiatry Neurosci. 2022 Aug 10;47(4):E299-E310. doi: 10.1503/jpn.210191. Print 2022 Jul-Aug. J Psychiatry Neurosci. 2022. PMID: 35948343 Free PMC article.
BACKGROUND: No established pharmacological treatment is available for the core symptoms of autism spectrum disorder (ASD). ...We searched from database inception to June 2021 for randomized controlled trials of antidepressan …
BACKGROUND: No established pharmacological treatment is available for the core symptoms of autism spectrum di …